Use access key #2 to skip to page content.
$19.05 -0.52 (-2.66%)
7/23/2008 4:00 PM

Omrix Biopharmaceuticals, Inc. (OMRI)

CAPS Rating:
*****

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

View All Commentary (OMRI)

Recs

0

Avatar DavidBear (26.33) Submitted: 5/14/08 9:25 AM : Outperform Start Price: $14.40 OMRI Score: 41.36

Insider buying, depressed price, PEG of 0.7.
What is not to like?

Report this Post Replies: 0 | Reply

Featured Broker Partners